Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(6/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(6/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Manufacturing
(263/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Serono
Oct 08, 2019
Sutro Biopharma to Receive Milestone Payment for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors
Sep 12, 2019
Menarini: Elcin Barker Ergun Group CEO
Sep 10, 2019
EMD Serono Initiates Pivotal Phase III Program for Investigational Evobrutinib in Relapsing Multiple Sclerosis
Aug 28, 2019
EMD Serono to Showcase Scientific Leadership at ECTRIMS 2019 with New Data Across Multiple Sclerosis Medicines
Jun 20, 2019
Massachusetts-based Business Sectors of Merck KGaA, Darmstadt, Germany Named 'Best Places to Work' by Boston Business Journal
Jun 03, 2019
Merck KGaA, Darmstadt, Germany Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with METex14 Skipping Mutations
May 28, 2019
EMD Serono to Present Data at CMSC Annual Meeting Showcasing Breadth of MS Portfolio and Commitment to Understanding How MS Impacts Patients
May 22, 2019
Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event
May 10, 2019
Positive Phase II Data Further Highlights Clinical Proof of Concept for Evobrutinib, First Oral Bruton's Tyrosine Kinase (BTK) Inhibitor to Report Positive Phase II Clinical Results in MS
May 07, 2019
EMD Serono Launches MS-LINK(TM), a Community to Advance MS Science and Improve Patient Lives
May 06, 2019
Intermolecular to be acquired by Merck KGaA, Darmstadt, Germany for $1.20 per share in an all cash transaction
Apr 30, 2019
EMD Serono to Present New Data on Mavenclad®, Rebif® and the Investigational Therapy Evobrutinib at the AAN Annual Meeting 2019
Apr 12, 2019
Merck KGaA, Darmstadt, Germany, Signs Definitive Agreement to Acquire Versum Materials for $53 per Share
Apr 08, 2019
MAVENCLAD® (Cladribine) Tablets Now Covered by Express Scripts
Apr 05, 2019
Elmar Schnee and Diane Parks Proposed as New Board Members of Calliditas Therapeutics
Apr 03, 2019
EvoNexus Technology Incubator in Partnership with EMD Performance Materials is Accepting Applications to Admit New Startups
Mar 29, 2019
FDA Approves MAVENCLAD® (Cladribine) Tablets as First and Only Short-Course Oral Treatment for Relapsing-Remitting and Active Secondary Progressive Multiple Sclerosis
Mar 14, 2019
Merck Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology
Mar 14, 2019
Merck KGaA, Darmstadt, Germany, Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology
Feb 28, 2019
EMD Serono to Present Multiple Sclerosis Data on Cladribine Tablets and Evobrutinib at ACTRIMS 2019
‹‹
Page 2
››
Latest News
Apr 20, 2024
nVent Electric plc to Release First Quarter 2024 Financial Results and Host Earnings Conference Call on...
Apr 20, 2024
Activated Carbon Global Strategic Business Report 2024-2030: Led by China, Asia-Pacific Enjoys Commanding...
Apr 20, 2024
AeroMech Announces RVSM Certification Program for Piper M700 Fury
Apr 20, 2024
Divert Announces Purchase of New Site in Lexington, North Carolina for Future Integrated Diversion &...
Apr 20, 2024
Scepter Simplifies Refueling with the Flip of a Switch
Apr 20, 2024
Global Large Caliber Ammunition Market Analysis and Forecasts, 2023-2024 and 2033: Smart Ammunition...
Apr 20, 2024
Arcline Completes Acquisition of Kaman
Apr 20, 2024
L3Harris Announces Quarterly Dividend
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events